| Literature DB >> 34822530 |
Elsayed Hafez1, Nourhan M Abd El-Aziz2, Amira M G Darwish2, Mohamed G Shehata2, Amira A Ibrahim1, Asmaa M Elframawy3, Ahmed N Badr4.
Abstract
Toxin-contaminated foods and beverages are a major source of illness, may cause death, and have a significant negative economic impact worldwide. Aflatoxin B1 (AFB1) is a potent toxin that may induce cancer after chronic low-level exposure. This study developed a quantitative recombinant AflR gene antiserum ELISA technique for aflatoxin B1 detection in contaminated food products. Aflatoxin B1 residuals from 36 food samples were analyzed with HPLC and VICAM. DNA was extracted from aflatoxin-contaminated samples and the AflR gene amplified using PCR. PCR products were purified and ligated into the pGEM-T vector. Recombinant plasmids were sequenced and transformed into competent E. coli (BL21). Molecular size and B-cell epitope prediction for the recombinant protein were assessed. The purified protein was used to induce the production of IgG antibodies in rabbits. Serum IgG was purified and labeled with alkaline phosphatase. Finally, indirect-ELISA was used to test the effectiveness of polyclonal antibodies for detection of aflatoxin B1 in food samples.Entities:
Keywords: HPLC; I-ELISA; VICAM; aflatoxin B1; milk powder; peanut; recombinant AflR gene; wheat flour
Mesh:
Substances:
Year: 2021 PMID: 34822530 PMCID: PMC8623882 DOI: 10.3390/toxins13110747
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
HPLC and VICAM screening analysis of 36 food samples for aflatoxin detection.
| Samples | HPLC | VICAM |
|---|---|---|
| Peanut 1 | +++ | +++ |
| Peanut 2 | +++ | ++ |
| Peanut 3 | +++ | +++ |
| Flour 1 | ++ | ++ |
| Flour 2 | +++ | ++ |
| Flour 3 | ++ | + |
| Milk-powder 1 | ++ | ++ |
| Milk-powder 2 | + | + |
| Milk-powder 3 | ++ | + |
+: refers to low aflatoxin contamination level; ++: refers to moderate aflatoxin contamination level; +++: refers to high aflatoxin contamination level.
Figure 1(A) PCR product amplified using the specific primers of the afIR gene (Aflatoxin B1). M: DNA marker and afIR the amplified gene in molecular size about 760 bp. (B) The recombinant protein of the in vitro transcribed afIR gene (Aflatoxin B1) with molecular size about 28 kDa.
Figure 2Phylogenetic tree for the amplified aflatoxin B1 based on the DNA nucleotide sequence and compared with the other 50 AFB1genes listed on gene bank. The phylogeny was constructed using Mega 6 program.
Predicted peptides with antigenic activity, their length, and positions.
| No. | Start | End | Peptide | Length | >aflIR d Deduced Amino Acid Sequence |
|---|---|---|---|---|---|
| 1 | 26 | 33 | LMQVPKIY | 8 | MSHSYNTFAGWFINTPTGRTQGSLA |
| 2 | 66 | 76 | EHYLLFLVQFV | 11 | YLAGNKSFLGSQPAHDGLRYLEPEACMRAGQL |
| 3 | 107 | 120 | TPQLVTFVYIHLDL | 14 | |
| 4 | 136 | 143 | FTLCVPPRLA | 8 | TARQSLGQVRT |
| 5 | 170 | 179 | PGRCVPPPRLA | 10 | ATLQEKAF |
| 6 | 186 | 196 | IAVRVVPVQKC | 11 | LTIFPPGHI |
| 7 | 205 | 215 | VLGVSNVVLPV | 11 | DAPRRNRP |
| 8 | 227 | 236 | RALPVPLIQL | 10 |
Figure 3The predicted antigenic activity of the recombinant protein (afIR).
Figure 4I-ELISA standard curve for AflR recombinant protein using purified serum IgG.
Comparative results obtained by HPLC, VICAM, specific PCR, and I-ELISA (ng/g).
| Sample | HPLC (ng/g) | VICAM (ng/g) | Specific PCR | ELISA |
|---|---|---|---|---|
| Peanut 1 | 3.26 ± 0.68 a | 5.86 ± 0.58 a | + | 3.43 ± 0.40 a,b |
| Peanut 2 | 2.83 ± 0.58 a | 5.46 ± 1.26 a | + | 4.76 ± 0.92 a |
| Peanut 3 | 2.50 ± 0.10 a | 6.20 ± 0.45 a | + | 2.36 ± 0.90 b,c |
| Flour 1 | 0.60 ± 0.23 b | 1.90 ± 0.36 c | + | 1.98 ± 0.94 b,c |
| Flour 2 | 0.44 ± 0.22 b | 1.83 ± 0.35 c | + | 3.33 ± 0.51 a,b |
| Flour 3 | 0.66 ± 0.15 b | 2.20 ± 0.20 c | + | 1.82 ± 1.01 c |
| Milk-powder 1 | 0.93 ± 0.71 b | 2.90 ± 0.70 b,c | + | 4.26 ± 0.81 a |
| Milk-powder 2 | 0.82 ± 0.50 b | 3.83 ± 0.55 b | + | 1.55 ± 0.67 c |
| Milk-powder 3 | 1.23 ± 0.62 b | 3.60 ± 0.91 b | + | 1.46 ± 0.84 c |
The mean values indicated in the same column within variable with different superscripts (a, b, and c) were significantly different (p < 0.05); +: present of fungal infection.
Figure 5Correlations between HPLC and VICAM (A), HPLC and ELISA (B), ELISA and VICAM (C).
Comparison between HPLC, VICAM, and validated method I-ELISA.
| Parameters | HPLC | VICAM | I-ELISA |
|---|---|---|---|
| Limit of detection | <0.008 ng/mL | <2 ng/mL | <1 ng/mL |
| Time of analysis | 120 min | 90 min | 30 min |
| Cost of analysis | High | Moderate | Moderate |
| Use of organic solvents | Yes | Yes | No |
Figure 6Polyclonal antibody production protocol.
Figure 7Summary of experimental steps.